title: A Randomized Controlled Study to Compare the Effects of Rosuvastatin 5 mg and Atorvastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-2).
abstract: OBJECTIVE
  For new evidence of aggressive lipid lowering treatment with statins in Japanese hypercholesterolemic patients, we performed an open-label, randomized, parallel-group comparative study to assess the effect of rosuvastatin 5 mg and atorvastatin 10 mg on plasma lipids.
  
  
  METHODS
  A total of 900 patients in whom the target control levels of LDL-cholesterol (LDL-C) set by the Japan Atherosclerosis Society Guidelines (JASGL2007) had not been achieved were randomly assigned to receive rosuvastatin 5 mg / day (n = 450) or atorvastatin 10 mg / day (n = 450) for 8 weeks. The primary endpoint was the percent change of LDL-C at week 8.
  
  
  RESULTS
  LDL-C was lowered by -44.5% (from 170.2 to 93.3 mg / dL) in the rosuvastatin group and -41.6% (from 169.5 to 97.9 mg / dL) in the atorvastatin group, at week 8 (P = 0.002 vs. atorvastatin). LDL-C / HDL-C ratio was lowered by -47.6% (from 3.01 to 1.56) and -43.5 % (from 2.96 to 1.66), respectively, at week 8 (P < 0.001 vs. atorvastatin). The changes in HDL-C, ApoB, ApoA-1, and ApoB / ApoA-1 ratio showed significant improvement in the rosuvastatin group than in the atorvastatin group. Adverse events were observed comparably between the rosuvastatin group (121 events) and the atorvastatin group (104 events). None of these events had adverse clinical consequence. Both drugs were well tolerated.
  
  
  CONCLUSIONS
  Rosuvastatin 5 mg produced significantly greater reduction in LDL-C and beneficial effect on other lipid parameters than atorvastatin 10 mg, and was also well tolerated.
authors.affiliation: Department of Clinical Epidemiology and Systems, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Yamazaki
authors.forename: Masahiko
authors.initials: M
authors.lastname: Kurabayashi
keywords: LDL-C; LDL-C / HDL-C ratio; guideline; statin
references.citation: Am J Cardiol. 2003 Jul 15;92(2):152-60
references.pmid: 12860216
references.citation: J Am Coll Cardiol. 2004 Jun 2;43(11):2142-6
references.pmid: 15172426
references.citation: J Atheroscler Thromb. 2003;10(6):329-36
references.pmid: 15037821
references.citation: Am J Cardiol. 2003 Jan 1;91(1):33-41
references.pmid: 12505568
references.citation: N Engl J Med. 2005 Apr 7;352(14):1425-35
references.pmid: 15755765
references.citation: N Engl J Med. 1996 Oct 3;335(14):1001-9
references.pmid: 8801446
references.citation: J Atheroscler Thromb. 2002;9(1):48-56
references.pmid: 12238638
references.citation: Lancet. 1994 Nov 19;344(8934):1383-9
references.pmid: 7968073
references.citation: J Atheroscler Thromb. 2004;11(3):152-8
references.pmid: 15256766
references.citation: Lancet. 2003 Apr 5;361(9364):1149-58
references.pmid: 12686036
references.citation: Curr Ther Res Clin Exp. 2005 Mar;66(2):80-95
references.pmid: 24672115
references.citation: JAMA. 2001 May 16;285(19):2486-97
references.pmid: 11368702
references.citation: Am J Cardiol. 2002 Feb 1;89(3):359-60
references.pmid: 11809445
references.citation: N Engl J Med. 2004 Apr 8;350(15):1495-504
references.pmid: 15007110
references.citation: Atherosclerosis. 1999 May;143 Suppl 1:S17-21
references.pmid: 10382834
references.citation: J Cardiovasc Risk. 2001 Dec;8(6):383-90
references.pmid: 11873095
references.citation: Circ J. 2007 Sep;71(9):1348-53
references.pmid: 17721009
references.citation: JAMA. 2007 Feb 7;297(5):499-508
references.pmid: 17284700
references.citation: N Engl J Med. 2008 Nov 20;359(21):2195-207
references.pmid: 18997196
references.citation: JAMA. 1997 Jul 23-30;278(4):313-21
references.pmid: 9228438
references.citation: N Engl J Med. 1995 Nov 16;333(20):1301-7
references.pmid: 7566020
references.citation: J Atheroscler Thromb. 2006 Apr;13(2):95-100
references.pmid: 16733297
references.citation: J Atheroscler Thromb. 2007 Apr;14(2):45-50
references.pmid: 17485887
references.citation: Am J Cardiol. 2001 Sep 1;88(5):504-8
references.pmid: 11524058
references.citation: Lancet. 2006 Sep 30;368(9542):1155-63
references.pmid: 17011942
references.citation: Lancet. 2004 Aug 21-27;364(9435):685-96
references.pmid: 15325833
references.citation: J Cardiol. 2005 Jan;45(1):1-10
references.pmid: 15700924
references.citation: JAMA. 1998 May 27;279(20):1615-22
references.pmid: 9613910